(this.webpackJsonpweb=this.webpackJsonpweb||[]).push([[0],{127:function(e,t,a){var n={"./approach/annotation.svg":627,"./approach/collecting.new.svg":628,"./approach/collecting.svg":629,"./approach/detailed_analysis.new.svg":630,"./approach/detailed_analysis.svg":631,"./approach/drugs-atc5-dendrogram-latest.png":632,"./approach/file_searching.svg":633,"./approach/file_system.svg":634,"./approach/files.svg":635,"./approach/kg.svg":636,"./approach/medical_research.new.svg":637,"./approach/medical_research.svg":638,"./approach/professor.new.svg":639,"./approach/professor.svg":640,"./approach/report.new.svg":641,"./approach/report.svg":642,"./approach/reviewed_docs.new.svg":643,"./approach/reviewed_docs.svg":644,"./approach/undraw_annotation_7das.svg":645,"./approach/undraw_collecting_fjjl.svg":646,"./approach/undraw_detailed_analysis_xn7y.svg":647,"./approach/undraw_medical_research_qg4d.svg":648,"./approach/undraw_professor_8lrt.svg":649,"./approach/undraw_report_mx0a.svg":650,"./approach/undraw_reviewed_docs_neeb.svg":651,"./data/chartdata":25,"./data/chartdata.js":25,"./logo.min.svg":207,"./logo.svg":97,"./logo.white.svg":652,"./logos/FacInformatica.jpg":653,"./logos/Logo_OEG.jpg":654,"./logos/image.png":655,"./logos/oeg.jpg":656,"./logos/upm.png":657,"./teamImages/Fotos/200.png":658,"./teamImages/Fotos/AlbaFernandez.png":659,"./teamImages/Fotos/AnaIglesiasMolina.jpg":660,"./teamImages/Fotos/BeatrizL\xf3pezCenteno.jpg":661,"./teamImages/Fotos/CarlosBadenesOlmedo.png":662,"./teamImages/Fotos/DanielBermejoS\xe1nchez.jpg":663,"./teamImages/Fotos/DavidChaves.jpg":664,"./teamImages/Fotos/EdnaRuckhaus.png":665,"./teamImages/Fotos/ElviraAmador.JPG":666,"./teamImages/Fotos/EstebanGonz\xe1lezGuardia.jpeg":667,"./teamImages/Fotos/Ignacio-IkerPrado-Rujas.jpg":668,"./teamImages/Fotos/JU_N.jpg":669,"./teamImages/Fotos/MariaPoveda.jpg":670,"./teamImages/Fotos/MaydadePabloLlorente.png":671,"./teamImages/Fotos/OscarCorcho.jpeg":672,"./teamImages/Fotos/PabloCallejaIba\xf1ez.jpg":673,"./teamImages/Fotos/PaolaEspinozaArias.jpg":674,"./teamImages/Fotos/PatriciaMart\xednChozas.png":675,"./teamImages/Fotos/SocorroBernardos.png":676,"./teamImages/Fotos/VirginiadePablo.png":677,"./teamImages/Fotos/asuncion.jpg":678,"./teamImages/Fotos/luisPozo.png":679,"./teamImages/yoHead.png":680};function i(e){var t=o(e);return a(t)}function o(e){if(!a.o(n,e)){var t=new Error("Cannot find module '"+e+"'");throw t.code="MODULE_NOT_FOUND",t}return n[e]}i.keys=function(){return Object.keys(n)},i.resolve=o,e.exports=i,i.id=127},207:function(e,t,a){e.exports=a.p+"static/media/logo.min.c1d79895.svg"},25:function(e,t,a){"use strict";a.r(t);t.default={MedicineStock:{values:[{Medicine:"TRANGOREX","n\xba Centers":3205},{Medicine:"DOLQUINE","n\xba Centers":2846},{Medicine:"TRANKIMAZIN","n\xba Centers":2032},{Medicine:"TRANKIMAZIN RETARD","n\xba Centers":2979},{Medicine:"MAXALT MAX","n\xba Centers":1820},{Medicine:"PARACETAMOL CINFA EFG","n\xba Centers":1436},{Medicine:"ADOFEN","n\xba Centers":1432},{Medicine:"NITRODERM TTS","n\xba Centers":1031},{Medicine:"DOLOCATIL CODEINA","n\xba Centers":1887},{Medicine:"ELECOR","n\xba Centers":1643}],xField:"Medicine",yField:"n\xba Centers",xAxis:{label:{visible:!1,autoRotate:!0,autoHide:!0}}},pie:{labels:["Ingl\xe9s","Italiano","Espa\xf1ol"],datasets:[{data:[300,50,100],backgroundColor:["#FF6384","#36A2EB","#FFCE56"],hoverBackgroundColor:["#FF6384","#36A2EB","#FFCE56"]}]},ArticlesPerYear:{values:[{year:"1970",value:6},{year:"1971",value:1},{year:"1972",value:4},{year:"1973",value:10},{year:"1974",value:6},{year:"1975",value:12},{year:"1976",value:17},{year:"1977",value:23},{year:"1978",value:25},{year:"1979",value:30},{year:"1980",value:29},{year:"1981",value:51},{year:"1982",value:39},{year:"1983",value:54},{year:"1984",value:57},{year:"1985",value:73},{year:"1986",value:88},{year:"1987",value:104},{year:"1988",value:116},{year:"1989",value:110},{year:"1990",value:115},{year:"1991",value:149},{year:"1992",value:142},{year:"1993",value:129},{year:"1994",value:122},{year:"1995",value:146},{year:"1996",value:107},{year:"1997",value:102},{year:"1998",value:106},{year:"1999",value:102},{year:"2000",value:116},{year:"2001",value:171},{year:"2002",value:154},{year:"2003",value:407},{year:"2004",value:905},{year:"2005",value:961},{year:"2006",value:1079},{year:"2007",value:1163},{year:"2008",value:1318},{year:"2009",value:1492},{year:"2010",value:1573},{year:"2011",value:1764},{year:"2012",value:1859},{year:"2013",value:2071},{year:"2014",value:2232},{year:"2015",value:2438},{year:"2016",value:2588},{year:"2017",value:2592},{year:"2018",value:2822},{year:"2019",value:2919},{year:"2020",value:2478}],xField:"year",yField:"value",xAxis:{type:"time",tickCount:20,mask:"YYYY"}},radar:{labels:["Efecto1","Efecto2","Efecto3","Efecto4","Efecto5","Efecto6","Efecto7"],datasets:[{label:"Medicamento 1",backgroundColor:"rgba(179,181,198,0.2)",borderColor:"rgba(179,181,198,1)",pointBackgroundColor:"rgba(179,181,198,1)",pointBorderColor:"#fff",pointHoverBackgroundColor:"#fff",pointHoverBorderColor:"rgba(179,181,198,1)",data:[65,59,90,81,56,55,40]},{label:"Medicamento 2",backgroundColor:"#0A7AA360",borderColor:"#60a5ff",pointBackgroundColor:"#60a5ff",pointBorderColor:"#fff",pointHoverBackgroundColor:"#fff",pointHoverBorderColor:"#60a5ff",data:[28,48,40,19,96,27,100]}]},donut:{labels:["RDF","PDF","JSON","CSV","TXT"],datasets:[{data:[150,210,300,50,100],backgroundColor:["#FF6384","#36A2EB","#FFCE56","#acbea3","#a2666f"],hoverBackgroundColor:["#FF6384","#36A2EB","#FFCE56","#acbea3","#a2666f"]}]},bubble:{labels:["January"],datasets:[{label:"Nombre comercial: KALETRA",fill:!1,lineTension:.1,backgroundColor:"#ff003794",borderColor:"rgba(75,192,192,1)",borderDash:[],borderDashOffset:0,borderJoinStyle:"miter",pointBorderColor:"#fa541c",pointBackgroundColor:"#fff",pointBorderWidth:1,pointHoverRadius:5,pointHoverBackgroundColor:"#fa541c",pointHoverBorderColor:"rgba(220,220,220,1)",pointHoverBorderWidth:2,pointRadius:1,pointHitRadius:10,data:[{x:15,y:50,r:35},{x:0,y:0,r:0},{x:0,y:100,r:0},{x:50,y:0,r:0},{x:50,y:100,r:0}]},{label:"Principio activo: LOPINAVIR",fill:!1,lineTension:.1,backgroundColor:"rgba(244, 77, 59, 0.6)",borderColor:"rgba(75,192,192,1)",borderDash:[],borderDashOffset:0,borderJoinStyle:"miter",pointBorderColor:"rgba(75,192,192,1)",pointBackgroundColor:"#fff",pointBorderWidth:1,pointHoverRadius:5,pointHoverBackgroundColor:"rgba(75,192,192,1)",pointHoverBorderColor:"rgba(220,220,220,1)",pointHoverBorderWidth:2,pointRadius:1,pointHitRadius:10,data:[{x:15,y:75,r:55},{x:0,y:0,r:0},{x:0,y:100,r:0},{x:50,y:0,r:0},{x:50,y:100,r:0}]},{label:"Principio activo: RITONAVIR",fill:!1,lineTension:.1,backgroundColor:"rgba(147, 12, 196, 0.5)",borderColor:"rgba(75,192,192,1)",borderDash:[],borderDashOffset:0,borderJoinStyle:"miter",pointBorderColor:"rgba(75,192,192,1)",pointBackgroundColor:"#fff",pointBorderWidth:1,pointHoverRadius:5,pointHoverBackgroundColor:"rgba(75,192,192,1)",pointHoverBorderColor:"rgba(220,220,220,1)",pointHoverBorderWidth:2,pointRadius:1,pointHitRadius:10,data:[{x:25,y:80,r:55},{x:0,y:0,r:0},{x:0,y:100,r:0},{x:50,y:0,r:0},{x:50,y:100,r:0}]},{label:"Grupo terap\xe9utico: J05AR10",fill:!1,lineTension:.1,backgroundColor:"#008f7ab3",borderColor:"rgba(75,192,192,1)",borderDash:[],borderDashOffset:0,borderJoinStyle:"miter",pointBorderColor:"rgba(75,192,192,1)",pointBackgroundColor:"#fff",pointBorderWidth:1,pointHoverRadius:5,pointHoverBackgroundColor:"rgba(75,192,192,1)",pointHoverBorderColor:"rgba(220,220,220,1)",pointHoverBorderWidth:2,pointRadius:1,pointHitRadius:10,data:[{x:22,y:40,r:45},{x:0,y:0,r:0},{x:0,y:100,r:0},{x:50,y:0,r:0},{x:50,y:100,r:0}]}]},graph:{nodes:[{id:"Harry"},{id:"Sally"},{id:"Alice"}],links:[{source:"Harry",target:"Sally"},{source:"Harry",target:"Alice"}]},graphConfig:{node:{color:"lightgreen",size:500,highlightStrokeColor:"blue"},link:{highlightColor:"lightblue"}},teamData:[{source:"teamImages/Fotos/OscarCorcho.jpeg",name:"Oscar Corcho",role:"Promoter",group:"Support",institution:"UPM",twitter:"ocorcho",github:"ocorcho",linkedin:"https://www.linkedin.com/in/ocorcho/",email:"ocorcho@fi.upm.es"},{source:"teamImages/Fotos/asuncion.jpg",name:"Asun G\xf3mez-P\xe9rez",role:"Promoter",group:"Support",institution:"UPM",twitter:"asungomezperez",github:"",linkedin:"http://www.dia.fi.upm.es/es/asun",email:"asun@fi.upm.es"},{source:"teamImages/Fotos/DavidChaves.jpg",name:"David Chaves",role:"Knowledge Engineer",group:"KG",institution:"UPM",twitter:"dchavesf",github:"dachafra",linkedin:"https://www.linkedin.com/in/david-chaves-fraga/",email:"dchaves@fi.upm.es"},{source:"teamImages/Fotos/CarlosBadenesOlmedo.png",name:"Carlos Badenes-Olmedo",role:"Product Owner",group:"NLP",institution:"UPM",twitter:"carbadol",github:"cbadenes",linkedin:"https://www.linkedin.com/in/cbadenes",email:"cbadenes@fi.upm.es"},{source:"teamImages/Fotos/luisPozo.png",name:"Luis Pozo",role:"Developer",group:"DEV",institution:"UPM",twitter:"LuispozoDev",github:"w0xter",linkedin:"https://www.linkedin.com/in/luis-pozo-472b6317a/",email:"luis.pozo@upm.es"},{source:"teamImages/Fotos/PatriciaMart\xednChozas.png",name:"Patricia Mart\xedn-Chozas",role:"Linguist",group:"NLP",institution:"UPM",twitter:"pmchozas",github:"pmchozas",linkedin:"https://www.linkedin.com/in/pmchozas/",email:"pmchozas@fi.upm.es"},{source:"teamImages/Fotos/MariaPoveda.jpg",name:"Mar\xeda Poveda-Villal\xf3n",role:"Ontologist",group:"KG",institution:"UPM",twitter:"MariaPovedaV",github:"mariapoveda",linkedin:"https://www.linkedin.com/in/mpovedavillalon",email:"mpoveda@fi.upm.es"},{source:"teamImages/Fotos/AlbaFernandez.png",name:"Alba Fern\xe1ndez-Izquierdo",role:"Ontologist",group:"KG",institution:"UPM",twitter:"albafizq",github:"albaizq",linkedin:"https://www.linkedin.com/in/albafernandezizquierdo/",email:"albafernandez@fi.upm.es"},{source:"teamImages/Fotos/AnaIglesiasMolina.jpg",name:"Ana Iglesias-Molina",role:"Knowledge Engineer",group:"KG",institution:"UPM",twitter:"_aieme",github:"anaigmo",linkedin:"https://www.linkedin.com/in/ana-iglesias-molina/",email:"ana.iglesiasm@upm.es"},{source:"teamImages/Fotos/PaolaEspinozaArias.jpg",name:"Paola Espinoza-Arias",role:"Ontologist",group:"KG",institution:"UPM",twitter:"mijaspao",github:"paoespinozarias",linkedin:"https://www.linkedin.com/in/paolaespinoza-arias/",email:"pespinoza@fi.upm.es"},{source:"teamImages/Fotos/PabloCallejaIba\xf1ez.jpg",name:"Pablo Calleja Ib\xe1\xf1ez",role:"Computational Linguistic",group:"NLP",institution:"UPM",twitter:"SPabloCalleja",github:"serpablo",linkedin:"https://www.linkedin.com/in/pablo-calleja-ib%C3%A1%C3%B1ez-63799064/",email:"pcalleja@fi.upm.es"},{source:"teamImages/Fotos/VirginiadePablo.png",name:"Virginia de Pablo",role:"Comunicaci\xf3n",group:"Support",institution:"UPM",twitter:"v_depablo",github:"",linkedin:"https://www.linkedin.com/in/vdepablo/",email:"vdepablo@fi-upm.es"},{source:"teamImages/Fotos/DanielBermejoS\xe1nchez.jpg",name:"Daniel Bermejo S\xe1nchez",role:"Back End Programmer",group:"CS",institution:"UPM",twitter:"",github:"",linkedin:"https://www.linkedin.com/in/daniel-bermejo-s\xe1nchez-020712160",email:"daniel.bermejos@alumnos.upm.es"},{source:"teamImages/Fotos/ElviraAmador.JPG",name:"Elvira Amador Dom\xednguez",role:"Machine Learning Engineer",group:"NLP",institution:"UPM",twitter:"elviamador",github:"eamadord",linkedin:"https://www.linkedin.com/in/elvira-amador-dom%C3%ADnguez-746607116/",email:"eamador@fi.upm.es"},{source:"teamImages/Fotos/EdnaRuckhaus.png",name:"Edna Ruckhaus Magnus",role:"Knowledge Graph exploitation",group:"KG",institution:"UPM",twitter:"eruckhaus",github:"ednaru",linkedin:"https://www.linkedin.com/in/eruckhaus/",email:"eruckhaus@fi.upm.es"},{source:"teamImages/Fotos/SocorroBernardos.png",name:"Socorro Bernardos Galindo",role:"Ayuda en ontolog\xeda y consultas",group:"KG",institution:"UPM",twitter:"",github:"",linkedin:"",email:""},{source:"teamImages/Fotos/EstebanGonz\xe1lezGuardia.jpeg",name:"Esteban Gonz\xe1lez Guardia",role:"Frontend programmer",group:"CS",institution:"UPM",twitter:"eglezguardia",github:"esgg",linkedin:"",email:"egonzalez@fi.upm.es"},{source:"teamImages/Fotos/BeatrizL\xf3pezCenteno.jpg",name:"Beatriz L\xf3pez Centeno",role:"Hospital Pharmacist",group:"Support",institution:"SERMAS",twitter:"blopezcenteno",github:"",linkedin:"https://www.linkedin.com/in/blopezcenteno/",email:"blcenteno@salud.madrid.org"},{source:"teamImages/Fotos/JU_N.jpg",name:"Juan Utande",role:"Advisor",group:"Support",institution:"UPM",twitter:"jutande",github:"",linkedin:"https://www.linkedin.com/in/juan-utande/",email:"jutande@fi.upm.es"},{source:"teamImages/Fotos/MaydadePabloLlorente.png",name:"Mayda de Pablo Llorente",role:"Support",group:"Support",institution:"",twitter:"maydadepablo",github:"",linkedin:"https://www.linkedin.com/in/maydadepablo/",email:"mayda.depablo.llorente@alumnos.upm.es"}],languages:[{info:{title1:"DRUGS4COVID",text1:"Queremos crear un cat\xe1logo de medicamentos usados para combatir la COVID-19, seg\xfan la literatura cient\xedfica, mediante el uso de t\xe9cnicas de Inteligencia Artificial y Ciencia Ciudadana.",videoLink:"https://www.youtube.com/embed/EygR2P_pkyc"},problems:{title0:"Problema",title1:"Las reservas de medicamentos en los servicios de farmacia de los hospitales se est\xe1n agotando",text1:"Con el aumento del n\xfamero de pacientes afectados por la COVID-19 e ingresados en las Unidades de Cuidados Intensivos en todo el mundo, se ha incrementado la demanda de los medicamentos necesarios para su tratamiento. Los laboratorios han aumentado la producci\xf3n, y desde la propia Agencia del Medicamento recuerdan que un mismo principio activo puede encontrar en m\xe1s de un nombre comercial.\nDurante a\xf1os, se ha generado una amplia cantidad de literatura cient\xedfica una gran ayuda y, al mismo tiempo, un problema para su exploraci\xf3n.",graph1:{title:"Farmacias sin Stock de cierto medicamento",subtitle:"N\xfamero de farmacias sin stock de un medicamento espec\xedfico desde 3-23-2020 hsata 3-29-2020"}},resources:{title0:"La soluci\xf3n se convierte en un nuevo problema",title1:"CORD-19",text1:"Esta riqueza de documentaci\xf3n cient\xedfica supone al mismo tiempo el problema. Si una persona desea conocer la aplicaci\xf3n o uso de un medicamento en el tratamiento de la COVID-19 o identificar las relaciones entre medicamentos descritos en un protocolo de actuaci\xf3n, debe navegar por este gran corpus de documentaci\xf3n donde los medicamentos aparecen mencionados con distintos nombres (principio activo, nombre comercial, grupo terape\xfatico\u2026). En ocasiones la menci\xf3n de un medicamento informa de su posible utilizaci\xf3n y en otros casos puede tratarse de una frase sin relevancia para este objetivo.",graph1:{title:"Art\xedculos por a\xf1o",subtitle:"Numero de publicaciones desde 1976 hasta febrero de 2020"},graphtext1:"Muchas Fuentes entre las que consultar.",graphtext2:"La nomenclatura de los medicamentos var\xeda seg\xfan el contexto.",title2:"Algunos datos:"},approach:{title0:"Nuestro Enfoque",text1:"\xbfC\xf3mo funciona?",data:[{step:1,title:"Procesar",content:"Procesar e indexar el corpus de art\xedculos, y todas las frases.",source:"approach/file_searching.svg",info:{motivation:{title:"Motivaci\xf3n",text:"Facilitar el procesamiento autom\xe1tico de las publicaciones cient\xedficas disponibles en el corpus CORD-19."},problems:{title:"Problemas",text:"El corpus se distribuye en varias colecciones de documentos comprimidas (formato GZ) y un archivo con metainformaci\xf3n (formato CSV)."},hypothesis:{title:"Hip\xf3tesis",text:"Almacenar los art\xedculos en repositorios orientados a documentos permitir\xe1 que puedan ser procesados y anotados autom\xe1ticamente mediante su interfaz de acceso HTTP."},methodology:{title:"Metodolog\xeda",lists:[[{type:"link",link:"https://pages.semanticscholar.org/coronavirus-research",text:"Descargar corpus CORD-19"},{type:"value",text:"Descargar metadatos en formato CSV"},{type:"value",text:"Descargar art\xedculos de la colecci\xf3n 'Commercial use subset' (16763 art\xedculos en formato JSON)"},{type:"value",text:"Descargar art\xedculos de la colecci\xf3n 'Non-commercial use subset ' (4228 art\xedculos en formato JSON)"},{type:"value",text:"Descargar art\xedculos de la colecci\xf3n 'Custom license subset ' (19171 art\xedculos en formato JSON)"},{type:"value",text:"Descargar art\xedculos de la colecci\xf3n 'bioRxiv/medRxiv subset' (500 art\xedculos en formato JSON)"},{type:"value",text:"Creaci\xf3n \xedndice en Solr para almacenar los art\xedculos"},{type:"value",text:"Desarrollo c\xf3digo Python para lectura de art\xedculos y registro en \xedndice en Solr"},{type:"value",text:"Segmentaci\xf3n de art\xedculos en frases"},{type:"value",text:"Creaci\xf3n \xedndice en Solr para almacenar los frases"},{type:"value",text:"Desarrollo c\xf3digo Python para extracci\xf3n de frases a partir del texto de los art\xedculos y registro en \xedndice en Solr"},{type:"value",text:"Creaci\xf3n de visualizaciones estad\xedsticas para la exploraci\xf3n de los art\xedculos"}]]},results:{title:"Resultados",lists:[[{type:"link",text:"Repositorio de documentos",link:"http://librairy.linkeddata.es/data/#/covid/core-overview"},{type:"link",text:"Repositorio de frases",link:"http://librairy.linkeddata.es/data/#/covid-sentences/core-overview"},{type:"link",text:"Visualizaci\xf3n Repositorio (c\xf3digo GIST 4f726911fd9908ffc3a46837b15d8011)",link:"https://librairy.linkeddata.es/data/dashboard"},{type:"link",text:"Exploraci\xf3n guiada por art\xedculos relacionados a partir de su contenido y sus anotaciones",link:"https://librairy.github.io/covid19/explorer.html"},{type:"link",text:"C\xf3digo de Python para el indexado",link:"https://github.com/librairy/covid19/blob/master/parallel-index-articles.py"}]]},conclusions:{title:"Conclusiones",statistics:{"Art\xedculos Indexados":"33244","Frases Extra\xeddas Autom\xe1ticamente":"5298063"}}}},{step:2,title:"Clasificar",content:"Anotar cada art\xedculo y cada frase con la informaci\xf3n procesada.",source:"approach/annotation.svg",info:{motivation:{title:"Motivaci\xf3n",text:"Agrupar medicamentos relacionados en el tratamiento del COVID para poder utilizarlos en situaciones de desabastecimiento."},problems:{title:"Problemas",text:"text",lists:[[{type:"value",text:"Procesamiento masivo de Art\xedculos cient\xedficos"},{type:"value",text:"Identificaci\xf3n autom\xe1tica de medicamentos"},{type:"value",text:"Identificaci\xf3n autom\xe1tica de s\xedntomas"},{type:"value",text:"Identificaci\xf3n autom\xe1tica de enfermedades"},{type:"value",text:"Identificaci\xf3n autom\xe1tica de trastornos"}],{title:"Descubrimiento de relaciones:",data:[{type:"value",text:"Medicamento vs S\xedntoma"},{type:"value",text:"Medicamento vs Enfermedad"},{type:"value",text:"Medicamento vs Trastorno"}]}]},hypothesis:{title:"Hip\xf3tesis",text:"La caracterizaci\xf3n de medicamentos mediante s\xedntomas, enfermedades y trastornos extra\xeddos autom\xe1ticamente de la literatura cient\xedfica permitir\xe1 agrupar aquellos que est\xe9n relacionados."},methodology:{title:"Metodolog\xeda",lists:[[{type:"link",text:"Creaci\xf3n servicio identificaci\xf3n medicamentos y c\xf3digos ATC",link:"http://librairy.github.io/bio-nlp"},{type:"value",text:"Desarrollo y ejecuci\xf3n de un anotador de enfermedades y medicamentos basado en modelos de identificaci\xf3n de entidades (NER). Anotaci\xf3n a dos niveles de profundidad: frase y art\xedculo"},{type:"value",text:"Construcci\xf3n de modelos de agrupamiento global y jer\xe1rquico a partir de las representaciones de los medicamentos obtenidas con las anotaciones."}],{title:"Evaluaci\xf3n de los resultados obtenidos:",data:[{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_2.png",text:"Para 100 Grupos (0.436208445103141)"},{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_3.png",text:"Para 110 Grupos (0.4494331459873356)"},{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_4.png",text:"Para 120 Grupos (0.4576435692957037)"},{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_5.png",text:"Para 130 Grupos (0.4553701275038375)"},{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_6.png",text:"Para 140 Grupos (0.46024923069398316)"}]}]},results:{title:"Resultados",lists:[{title:"Anotaciones: 5.274.655 frases y 33.244 art\xedculos",data:[{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=scispacy_diseases_t",text:"Enfermedades (scipacy_diseases_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid/terms?terms.fl=annot_cliner_problems_t",text:"S\xedntomas (annot_cliner_problems_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid/terms?terms.fl=annot_cliner_treatments_t",text:"Trastornos (annot_cliner_treatments_t)"},{type:"title",text:"Medicamentos:"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=scispacy_chemicals_t",text:"sustancia qu\xedmica: (scispacy_chemicals_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=bionlp_atc5_t",text:"principio activo (bionlp_atc5_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=bionlp_atc4_t",text:"grupo terape\xfatico (bionlp_atc4_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=bionlp_atc3_t",text:"grupo qu\xedmico (bionlp_atc3_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=bionlp_atc2_t",text:"grupo farmacol\xf3gico (bionlp_atc2_t)"},{type:"image",text:"",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/annotations-donut2.png"}]},{title:"Distribuci\xf3n de los medicamentos a partir de las anotaciones",data:[{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/drugs-atc5-bidimensional-latest.png",text:"En espacio bi-dimensional"},{type:"image",link:"https://raw.githubusercontent.com/oeg-upm/drugs4covid19web/master/web/src/assets/approach/drugs-atc5-dendrogram-latest.png",text:"Por niveles"}]}]},conclusions:{title:"Conclusiones",lists:[[{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/drugs-atc5-cluster-latest.png",text:"Se han identificado 120 grupos de medicamentos de entre todos los mencionados en art\xedculos publicados en CORD-19"},{type:"value",text:"A partir de un medicamento, ya sea desde su nombre comercial, grupo farmacol\xf3gico, terape\xfatico o principio activo, se pueden sugerir medicamentos relacionados."},{type:"value",text:"Se pueden realizar b\xfasquedas basadas en enfermedades, s\xedntomas, tratamientos o medicamentos de los art\xedculos cient\xedficos publicados en CORD-19."},{type:"link",caption:"(Los medicamentos que combinan la actividad inmunosupresora y antimal\xe1rica tienen el principio activo P01BA02; los antibi\xf3ticos macr\xf3lidos pertenecen al grupo terape\xfatico J01FA)",link:"https://librairy.linkeddata.es/solr/covid/select?fl=url_s%2C%20name_s%2C%20scispacy_diseases_t&q=labels4_t%3AJ01FA%20AND%20labels5_t%3AP01BA02",text:"Por ejemplo, responder a la siguiente pregunta: \xbfse han usado medicamentos que combinan actividad inmunosupresora y antimal\xe1rica con antibi\xf3ticos macr\xf3lidos? \xbfEn qu\xe9 documentos se mencionan, y relacionados con qu\xe9 enfermedades?"},{type:"image",link:"https://taiga.vencealvirus.software.imdea.org/media/attachments/7/4/2/c/88032427ea5df8abb15780aed503ade41f27500d1dbe735178f6f96e8986/diseaseschemicals-atcs2.png#_taiga-refresh=wiki_page:1361",text:"No todas las frases pertenecientes al corpus contienen entidades de relevancia, y en la gran mayor\xeda solo aparece 1"},{type:"value",text:"No se detallan suficientes relaciones entre entidades a nivel de frase. Otras tareas adicionales como la identificaci\xf3n de correferencias para trabajar a nivel de p\xe1rrafo y generaci\xf3n de nuevos modelos para el corpus espec\xedfico se contemplan como l\xedneas futuras"}],{title:"Medicamentos relacionados con el Aciclovir (J05AB01) en este contexto",data:[{type:"value",link:"",text:"ketamine (N01AX03)"},{type:"value",link:"",text:"piperazine (P02CB01)"},{type:"value",link:"",text:"acefylline piperazine (R03DA09)"},{type:"value",link:"",text:"barium sulfate without suspending agents (V08BA02)"},{type:"value",link:"",text:"barium sulfate with suspending agents (V08BA01)"},{type:"value",link:"",text:"chlorhexidine (S01AX09, S03AA04, S02AA09, D09AA12, R02AA05, B05CA02, D08AC02, A01AB03)"},{type:"value",link:"",text:"chlorhexidine, combinations (D08AC52)"},{type:"value",link:"",text:"artesunate (P01BE03)"},{type:"value",link:"",text:"artesunate and pyronaridine (P01BF06)"},{type:"value",link:"",text:"amodiaquine (P01BA06)"}]}]}}},{step:3,title:"Validar",content:"Revisar estas anotaciones con la ayuda de cient\xedficos ciudadanos.",source:"approach/medical_research.svg",info:{motivation:{title:"Motivaci\xf3n",text:"Validar las frases extra\xeddas de los art\xedculos que tratan sobre el COVID-19 por ciudadanos con formaci\xf3n y conocimientos en Ciencias de la Salud."},problems:{title:"Problemas",text:"Las palabras clave relacionadas con la enfermedad (s\xedntomas, medicamentos, enfermedades y tratamientos) pueden aparecer en las frases en diferente orden y con un significado distinto, por lo que es dif\xedcil una interpretaci\xf3n autom\xe1tica."},hypothesis:{title:"Hip\xf3tesis",text:"El conocimiento e interpretaci\xf3n de los ciudadanos con formaci\xf3n y conocimientos en Ciencias de la Salud ser\xe1 clave para validar las frases extra\xeddas de los art\xedculos cient\xedficos que realiza el procesamiento autom\xe1tico."},methodology:{title:"Metodolog\xeda",lists:[[{type:"value",text:"Se construir\xe1 un experimento de ciencia ciudadana, a modo de aplicaci\xf3n web, que permita a los usuarios con formci\xf3n y conocimientos en ciencias de la salud validar las frases extra\xeddas por el sistema de Inteligencia Artificial."},{type:"value",text:"Los datos de entrada del experimento ser\xe1n las frases extra\xeddas del procesamiento autom\xe1tico."},{type:"value",text:"En cumplimiento de la GDPR, se informar\xe1 al usuario sobre c\xf3mo se van a tratar sus datos personales, derecho a creaci\xf3n de perfiles autom\xe1ticos y derecho al borrado cuando el usuario lo estime adecuado. Adem\xe1s, los datos permanecer\xe1n en servidores debidamente securizados."},{type:"value",text:"Todos los datos en bruto \xbfdel experimento? se publicar\xe1n en abierto, anonimizando previamente el identificador del usuario."}],{title:"La aplicaci\xf3n permitir\xe1:",data:[{type:"value",text:"Registrar usuarios y clasificarlos seg\xfan perfil (m\xe9dicos de familia, enfermeros, epidemi\xf3logos, farmac\xe9uticos, \u2026). Dicha clasificaci\xf3n se realizar\xe1 mediante la realizaci\xf3n de un tutorial"},{type:"value",text:"Se mostrar\xe1 al usuario una frase extra\xedda del corpus y marcar\xe1 en ella los s\xedntomas, medicamentos y posibles tratamientos."},{type:"value",text:"La aplicaci\xf3n registrar\xe1 cada una de las palabras o grupos de palabras marcadas por los usuarios."},{type:"value",text:"Los datos validados se enviar\xe1n a una API para su almacenamiento en una base de datos."},{type:"value",text:'Se calcular\xe1 un \xedndice de confianza para cada usuario, basado en "gold standards" (tareas previamente validadas por los expertos).'},{type:"link",link:"https://oeg-upm.github.io/drugs4covid19-cs/",text:"Prueba aqu\xed nuestro demo"}]}]},conclusions:{title:"Conclusi\xf3n",lists:[[{type:"value",text:"Conjunto y clasificaci\xf3n de los medicamentos adecuados para la enfermedad."},{type:"value",text:"Conjunto y clasificaci\xf3n de los s\xedntomas de la enfermedad."},{type:"value",text:"Relaci\xf3n s\xedntomas-medicamentos extra\xeddos de las frases."},{type:"value",text:"Relaci\xf3n medicamento-medicamento."},{type:"value",text:"Relaci\xf3n medicamento-enfermedad."}]]},results:{}}},{step:4,title:"Publicar",content:"Publicar un grafo de conocimientos con los datos que sean correctos.",source:"approach/kg.svg",info:{motivation:{title:"Motivaci\xf3n",text:"A partir del Corpus corpus CORD-19, un corpus actualizado de art\xedculos cient\xedficos sobre COVID-19 se han generado varios repositorios orientados a documentos que pueden ser procesados y anotados autom\xe1ticamente mediante su interfaz de acceso HTTP. El repositorio generado de frases de estos art\xedculos contiene anotaciones acerca de enfermedades, s\xedntomas y trastornos y tratamientos (c\xf3digos ATC) relacionados con el COVID-19. Actualmente existen diferentes repositorios de datos relacionados con estos aspectos que contienen una descripci\xf3n detallada de atributos tales como todos los nombres con los que se conoce una medicina, efectos secundarios, entre otros. Se quiere entonces extender las anotaciones generadas inicialmente con aquellas generadas por este tipo de relaciones. Para que la informaci\xf3n pueda ser explotada por tanto por personas vinculadas al \xe1mbito sanitario como por el p\xfablico en general, es necesario que las anotaciones est\xe9n alineadas a un vocabulario que describa este dominio del conocimiento. De esta manera, el repositorio original ser\xe1 transformado a un grafo de conocimiento (knowledge graph) mediante t\xe9cnicas que trabajan con mappings (correspondencias) entre el repositorio de frases y el vocabulario desarrollado."},problems:{title:"Problemas",lists:[[{type:"value",text:"Silos de informaci\xf3n"},{type:"value",text:"Fuentes de datos heterog\xe9neas"},{type:"value",text:"Diversidad de formatos y m\xe9todos de consulta"},{type:"value",text:"Carencia de vocabularios consensuados"}]]},hypothesis:{title:"Hip\xf3tesis",text:"Un punto de acceso \xfanico y unificado en forma de grafo permite recuperar informaci\xf3n sobre los medicamentos y sus interacciones de forma m\xe1s efectiva para los expertos."},methodology:{title:"Metodolog\xeda",lists:[[{type:"value",text:"B\xfasqueda y generaci\xf3n de fuentes de datos"},{type:"value",text:"B\xfasqueda de fuentes de conocimiento relacionadas a enfermedades, s\xedntomas y trastornos, tratamientos."},{type:"value",text:"Explorar otros repositorios sem\xe1nticos que han sido generados a partir de informaci\xf3n de COVID-19 para ver la posibilidad de relacionar los grafos de conocimiento."},{type:"value",text:"Generaci\xf3n del vocabulario con reuso de ontolog\xedas asociadas a esas fuentes."},{type:"value",text:"Documentaci\xf3n y publicaci\xf3n del vocabulario."},{type:"value",text:"Mapeo de los datos al vocabulario."},{type:"value",text:"Generaci\xf3n del grafo de conocimiento alineado con vocabulario."},{type:"value",text:"Enriquecimiento del grafo con validaciones de expertos (ciencia ciudadana)."},{type:"value",text:"Publicaci\xf3n del grafo de conocimiento"}]]},results:{title:"Resultados",lists:[[{type:"link",link:"https://w3id.org/def/DRUGS4COVID19",text:"Vocabulario"},{type:"link",link:"https://github.com/oeg-upm/drugs4covid19-kg",text:"Knowledge graph"},{type:"link",link:"http://librairy.linkeddata.es/sparql",text:"Punto de consulta"},{type:"link",link:"https://librairy.linkeddata.es/sparql?default-graph-uri=http%3A%2F%2Fdrugs4covid.com%2F542020&query=select+distinct+*+where+%7B%0D%0A%0D%0A%3Fs+a+%3Chttps%3A%2F%2Fw3id.org%2Fdef%2FDRUGS4COVID19%23Paper%3E.%0D%0A%3Fs+%3Chttps%3A%2F%2Fw3id.org%2Fdef%2FDRUGS4COVID19%2Fmenciona%3E+%3Fa+.%0D%0A%3Fa+%3Fp+%3Ft+.%0D%0A%0D%0A%7D+limit+10&should-sponge=&format=text%2Fhtml&timeout=0&debug=on&run=+Run+Query+",text:"Ejemplo de consulta"}]]},conclusions:{title:"Conclusiones",text:"Hemos integrado de forma estructurada la informaci\xf3n sacada de las art\xedculos cient\xedficos, sus anotaciones y adem\xe1s la hemos enriquecido con enlaces \xfatiles para los expertos a fuentes externas. De esta manera, esta fuente de informaci\xf3n \xfanica se puede utilizar para responder preguntas de forma r\xe1pida y sencilla."}}}]},team:{title0:"\xbfQui\xe9nes Somos?",title1:"El Equipo",title2:"Con la ayuda de:",logo1:"logos/oeg.jpg",logo2:"logos/upm.png",logo3:"logos/FacInformatica.jpg"}},{info:{title1:"DRUGS4COVID",text1:"We want to create a catalog of medicines used to combat COVID-19, according to scientific literature, through the use of Artificial Intelligence and Citizen Science techniques.",videoLink:"https://www.youtube.com/embed/EygR2P_pkyc"},problems:{title0:"Problem",title1:"Drugs in hospital pharmacy services are running low",text1:"With the increase in the number of patients affected by COVID-19 and admitted to Intensive Care Units throughout the world, the demand for the medicines necessary for their treatment has increased. Laboratories have increased production, and the Drug Agency itself recalls that the same active ingredient can be found in more than one trade name.\nFor years, a large amount of scientific literature has been generated, a great help and a problem for its exploration too.",graph1:{title:"Pharmacies without stock of a medicine",subtitle:"Number of pharmacies without stock of a specific medicine from 2020-03-23 to 2020-03-29"}},resources:{title0:"The solution becomes the problem",title1:"CORD-19",text1:"This scientific documentation is at the same time the problem. If a person wants to know the application or use of a drug in the treatment of COVID-19 or identify the relationships between drugs described in a protocol of action, they should navigate this large body of documentation where the drugs are mentioned with different names (active principle, trade name, therapeutic group... ). Sometimes the mention of a medicine informs about its possible use and in other cases it may be a phrase without relevance to this objective.",title2:"Some Data:",graph1:{title:"Articles per year",subtitle:"Number of published articles from 1970 to February 2020."},graphtext1:"Many sources to consult.",graphtext2:"The name of the medicine depends on the context."},approach:{title0:"Our Approach",text1:"How it works?",data:[{step:1,title:"Process",content:"Process and index the article corpus, and all the sentences.",source:"approach/file_searching.svg",info:{motivation:{title:"Motivation",text:"Ease the automatic processing of scientific publications available in CORD-19 corpus."},problems:{title:"Problems",text:"The corpus gathers several compressed collections of documents (GZ format) and a metadata file (CSV format)."},hypothesis:{title:"Hypothesis",text:"Storing the papers in document oriented repositories will allow their automatic processing and annotation through an HTTP access interface."},methodology:{title:"Methodology",lists:[[{type:"link",link:"https://pages.semanticscholar.org/coronavirus-research",text:"Download CORD-19 corpus"},{type:"value",text:"Download metadata in CSV"},{type:"value",text:"Download papers from the collection \u201cCommercial use subset\u201d (16763 papers in JSON)"},{type:"value",text:"Download papers from the collection \u201cNon-commercial use subset\u201d (4228 papers in JSON)"},{type:"value",text:"Download papers from the collection \u201cCustom license subset\u201d (19171 papers in JSON)"},{type:"value",text:"Download papers from \u201cbioRxiv/medRxiv subset\u201d (500 art\xedculos en formato JSON)"},{type:"value",text:"Creation of a Solr index to store the papers"},{type:"value",text:"Development of a Python script for paper reading and registration in the Solr index"},{type:"value",text:"Segmentation of papers in sentences"},{type:"value",text:"Creation of a Solr index to store the sentences"},{type:"value",text:"Development of a Python script to extract sentences from papers and registration in Solr index"},{type:"value",text:"Creation of statistical visualisations for paper exploration"}]]},results:{title:"Results",lists:[[{type:"link",text:"Document repository",link:"http://librairy.linkeddata.es/data/#/covid/core-overview"},{type:"link",text:"Sentence repository",link:"http://librairy.linkeddata.es/data/#/covid-sentences/core-overview"},{type:"link",text:"Visualisation repository (code: GIST 4f726911fd9908ffc3a46837b15d8011)",link:"https://librairy.linkeddata.es/data/dashboard"},{type:"link",text:"Guided exploration accross the related papers based on their content and annotations",link:"https://librairy.github.io/covid19/explorer.html"},{type:"link",text:"Python script for indexing",link:"https://github.com/librairy/covid19/blob/master/parallel-index-articles.py"}]]},conclusions:{title:"Conclusions",statistics:{"Indexed Papers":"33244","Automatically Extracted Sentences":"5298063"}}}},{step:2,title:"Classify",content:"Annotate each article and each sentence with the processed information.",source:"approach/annotation.svg",info:{motivation:{title:"Motivation",text:"Grouping drugs related with COVID 19 treatment to use them in shortage situations"},problems:{title:"Problems",text:"text",lists:[[{type:"value",text:"Massive processing of scientific papers"},{type:"value",text:"Automatic drug identification"},{type:"value",text:"Automatic symptom identification"},{type:"value",text:"Automatic disease identification"},{type:"value",text:"Automatic disorder identification"}],{title:"Relation Extraction:",data:[{type:"value",text:"Drug vs Symptom"},{type:"value",text:"Drug vs Disease"},{type:"value",text:"Drug vs Disorder"}]}]},hypothesis:{title:"Hypothesis",text:"The description of drugs by means of symptoms, diseases and disorders automatically extracted from the scientific publication will allow grouping those that are related."},methodology:{title:"Methodology",lists:[[{type:"link",text:"Creation of a service to identify drugs and ATC codes",link:"http://librairy.github.io/bio-nlp"},{type:"value",text:"Development and execution of a drug and disease annotator based of NER models."},{type:"value",text:"Annotations in two levels: sentence and paper."},{type:"value",text:"Generation of grouping models (global and hierarchical) apart from representations of the drugs obtained with the annotations."}],{title:"Evaluation of the results obtained:",data:[{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_2.png",text:"For 100 Groups (0.436208445103141)"},{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_3.png",text:"For 110 Groups (0.4494331459873356)"},{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_4.png",text:"For 120 Groups (0.4576435692957037)"},{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_5.png",text:"For 130 Groups (0.4553701275038375)"},{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_6.png",text:"For 140 Groups (0.46024923069398316)"}]}]},results:{title:"Results",lists:[{title:"Annotations: 5.274.655 sentences y 33.244 papers",data:[{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=scispacy_diseases_t",text:"Diseases (scipacy_diseases_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid/terms?terms.fl=annot_cliner_problems_t",text:"Symptoms (annot_cliner_problems_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid/terms?terms.fl=annot_cliner_treatments_t",text:"Disorders (annot_cliner_treatments_t)"},{type:"title",text:"Drugs:"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=scispacy_chemicals_t",text:"chemical substance: (scispacy_chemicals_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=bionlp_atc5_t",text:"active ingredient: (bionlp_atc5_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=bionlp_atc4_t",text:"therapeutic group: (bionlp_atc4_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=bionlp_atc3_t",text:"chemical group: (bionlp_atc3_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=bionlp_atc2_t",text:"pharmacological group: (bionlp_atc2_t)"},{type:"image",text:"",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/annotations-donut2.png"}]},{title:"Distribution of drugs from annotations",data:[{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/drugs-atc5-bidimensional-latest.png",text:"Bidimensional space"},{type:"image",link:"https://raw.githubusercontent.com/oeg-upm/drugs4covid19web/master/web/src/assets/approach/drugs-atc5-dendrogram-latest.png",text:"By levels"}]}]},conclusions:{title:"Conclusions",lists:[[{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/drugs-atc5-cluster-latest.png",text:"We have identified 120 groups of drugs amongst those mentioned in papers published in CORD-19"},{type:"value",text:"Given a drug, we can suggest related drugs based on its commercial name, pharmacological group, therapeutic group or active ingredient."},{type:"value",text:"We can make searches based on diseases, symptoms, treatments or drugs from the scientific papers published in CORD-19."},{type:"link",caption:"(Los medicamentos que combinan la actividad inmunosupresora y antimal\xe1rica tienen el principio activo P01BA02; los antibi\xf3ticos macr\xf3lidos pertenecen al grupo terape\xfatico J01FA)",link:"https://librairy.linkeddata.es/solr/covid/select?fl=url_s%2C%20name_s%2C%20scispacy_diseases_t&q=labels4_t%3AJ01FA%20AND%20labels5_t%3AP01BA02",text:"For instance, we can now answer to the next question: Have drugs that combine immunosuppressive and anti-malarial activity with macrolide antibiotic been used? In which papers are they mentioned? To which diseases are they related?"},{type:"image",link:"https://taiga.vencealvirus.software.imdea.org/media/attachments/7/4/2/c/88032427ea5df8abb15780aed503ade41f27500d1dbe735178f6f96e8986/diseaseschemicals-atcs2.png#_taiga-refresh=wiki_page:1361",text:"Not all the sentences belonging to this corpus contain relevant entities, and in the major part of the papers only one entity can be found."},{type:"value",text:"No se detallan suficientes relaciones entre entidades a nivel de frase. Otras tareas adicionales como la identificaci\xf3n de correferencias para trabajar a nivel de p\xe1rrafo y generaci\xf3n de nuevos modelos para el corpus espec\xedfico se contemplan como l\xedneas futuras"}],{title:"Drugs related with Aciclovir (J05AB01) in this context",data:[{type:"value",link:"",text:"ketamine (N01AX03)"},{type:"value",link:"",text:"piperazine (P02CB01)"},{type:"value",link:"",text:"acefylline piperazine (R03DA09)"},{type:"value",link:"",text:"barium sulfate without suspending agents (V08BA02)"},{type:"value",link:"",text:"barium sulfate with suspending agents (V08BA01)"},{type:"value",link:"",text:"chlorhexidine (S01AX09, S03AA04, S02AA09, D09AA12, R02AA05, B05CA02, D08AC02, A01AB03)"},{type:"value",link:"",text:"chlorhexidine, combinations (D08AC52)"},{type:"value",link:"",text:"artesunate (P01BE03)"},{type:"value",link:"",text:"artesunate and pyronaridine (P01BF06)"},{type:"value",link:"",text:"amodiaquine (P01BA06)"}]}]}}},{step:3,title:"Validate",content:"Review these notes with the help of citizen scientists.",source:"approach/medical_research.svg",info:{motivation:{title:"Motivation",text:"Validation of the sentences extracted from the papers that contain information about COVID-19 by citizens with knowledge in Health Science."},problems:{title:"Problems",text:"Keywords related with the disease (symptoms, drugs, diseases and treatments) can appear in different order and with a different meaning. Thus, the automatic identification is complex."},hypothesis:{title:"Hypothesis",text:"The knowledge and interpretation of citizens with experience in Health Science will be essential to validate the automatically extracted sentences from scientific papers."},methodology:{title:"Methodology",lists:[[{type:"value",text:"A web application on citizen science will be built. This application will allow the validation of the sentences extracted with an Artificial Intelligence system by users with experience in Health Science."},{type:"value",text:"The input data of the experiment will be the automatically extracted sentences."},{type:"value",text:"In compliance with the GDPR, users will be informed about the treatment of their personal data, the creation of automatic profiles and their right to delete them. Moreover, the servers will be duly secured."},{type:"value",text:"All the raw data from the experiment will be openly published (anonymising previously the user identifiers)."}],{title:"The application will allow:",data:[{type:"value",text:"Registration and classification of users as per their profile (general doctors, nurses, epidemiologists, pharmacists\u2026) Such classification will be made by performing a tutorial."},{type:"value",text:"A phrase extracted from the corpus will be shown to the user and will mark the symptoms, medications and possible treatments."},{type:"value",text:"The users will be shown a sentence extracted from the corpus and they will identify symptoms, drugs and treatments."},{type:"value",text:"Validated data will be sent to an API for their storage in a database."},{type:"value",text:"A confidence index will be calculated for every user, based on gold standards (tasks previously validated by experts)."},{type:"link",link:"https://oeg-upm.github.io/drugs4covid19-cs/",text:"Try here our demo."}]}]},results:{},conclusions:{title:"Conclusions",lists:[[{type:"value",text:"Collection and classification of adequate drugs for the disease."},{type:"value",text:"Collection and classification of symptoms of the disease."},{type:"value",text:"Relations symptom-drug extracted from the sentences."},{type:"value",text:"Relations drug-drug extracted from the sentences."},{type:"value",text:"Relations drug-disease extracted from the sentences."}]]}}},{step:4,title:"Publish",content:"Publish a knowledge graph with the valid data.",source:"approach/kg.svg",info:{motivation:{title:"Motivation",text:"Several document oriented repositories have been generated from the corpus CORD-19, an updated corpus of scientific papers in COVID-19. Documents can be automatically processed and annotated thanks to the HTTP access interface. The generated repository contains sentences from these papers annotated with diseases, symptoms, disorders and treatments (ATC codes) related with COVID-19. There currently are different repositories of related data that contain detailed descriptions of attributes such as the name of a drug or secondary effects, amongst others. Therefore, the idea is to extend initial annotations with those generated by this type of relations. In order to exploit the information, both for health science related people and general audience, the annotations need to be aligned with a vocabulary that describes the knowledge of the domain. This way, the original repository will be transformed into a knowledge graph by means of mappings between the sentence repository and the developed vocabulary."},problems:{title:"Problems",lists:[[{type:"value",text:"Information silos"},{type:"value",text:"Heterogeneous data sources"},{type:"value",text:"Heterogeneous formats and query methods"},{type:"value",text:"Lack of consolidated vocabularies"}]]},hypothesis:{title:"Hypothesis",text:"A unique and unified access point, graph shaped, allows an effective retrieval of information about drugs and their interactions."},methodology:{title:"Methodology",lists:[[{type:"value",text:"Search and generation of data sources"},{type:"value",text:"Search of knowledge sources related to drugs, symptoms, disorders and treatments"},{type:"value",text:"Exploration of other semantic repositories, generated with information on COVID-19, to research on the possibility of mapping knowledge graphs."},{type:"value",text:"Generation of the vocabulary by reusing ontologies associated to that sources."},{type:"value",text:"Documentation and publication of the vocabulary."},{type:"value",text:"Mapping the data with the vocabulary"},{type:"value",text:"Generation of the knowledge graph aligned with the vocabulary"},{type:"value",text:"Enrichment of the graph with expert validations (citizen science)"},{type:"value",text:"Publication of the knowledge graph"}]]},results:{title:"Results",lists:[[{type:"link",link:"https://w3id.org/def/DRUGS4COVID19",text:"Vocabulary"},{type:"link",link:"https://github.com/oeg-upm/drugs4covid19-kg",text:"Knowledge graph"},{type:"link",link:"http://librairy.linkeddata.es/sparql",text:"Sparql endpoint"},{type:"link",link:"https://librairy.linkeddata.es/sparql?default-graph-uri=http%3A%2F%2Fdrugs4covid.com%2F542020&query=select+distinct+*+where+%7B%0D%0A%0D%0A%3Fs+a+%3Chttps%3A%2F%2Fw3id.org%2Fdef%2FDRUGS4COVID19%23Paper%3E.%0D%0A%3Fs+%3Chttps%3A%2F%2Fw3id.org%2Fdef%2FDRUGS4COVID19%2Fmenciona%3E+%3Fa+.%0D%0A%3Fa+%3Fp+%3Ft+.%0D%0A%0D%0A%7D+limit+10&should-sponge=&format=text%2Fhtml&timeout=0&debug=on&run=+Run+Query+",text:"Query example"}]]},conclusions:{title:"Conclusions",text:"We have integrated and structured information extracted from scientific papers and their annotations. Moreover, we have enriched them with links to external resources, which is very useful for experts. This way, this unique information resource can be used to easily answer questions."}}}]},team:{title0:"Who Are We?",title1:"The Team",title2:"With the help of:",logo1:"logos/oeg.jpg",logo2:"logos/upm.png",logo3:"logos/FacInformatica.jpg"}}],navText:[{introduction:"Introduction",problem:"Problem",resources:"Resources",approach:"Approach",team:"Who Are We?",lang:"ES"},{introduction:"Introducci\xf3n",problem:"Problema",resources:"Recursos",approach:"Nuestro Enfoque",team:"\xbfQui\xe9nes Somos?",lang:"EN"}],List:{title:"Lopinavir + Ritonavir",items:[{title:"Active principie",description:"Lopinavir + Ritonavir"},{title:"ATC code",description:"J05AR10"},{title:"Trade name",description:"KALETRA 100 mg/25 mg"},{title:"Trade name",description:"LOPINAVIR/RITONAVIR ACCORD 200 MG/ 50 MG"},{title:"Trade name",description:"LOPINAVIR/RITONAVIR RANBAXY 100 MG/25 MG"}]}}},308:function(e,t,a){e.exports=a(705)},313:function(e,t,a){},314:function(e,t,a){e.exports=a.p+"static/media/logo.5d5d9eef.svg"},627:function(e,t,a){e.exports=a.p+"static/media/annotation.2c34bd7f.svg"},628:function(e,t,a){e.exports=a.p+"static/media/collecting.new.9c5b1003.svg"},629:function(e,t,a){e.exports=a.p+"static/media/collecting.a457acbb.svg"},630:function(e,t,a){e.exports=a.p+"static/media/detailed_analysis.new.051a5c5c.svg"},631:function(e,t,a){e.exports=a.p+"static/media/detailed_analysis.36330695.svg"},632:function(e,t,a){e.exports=a.p+"static/media/drugs-atc5-dendrogram-latest.374a5347.png"},633:function(e,t,a){e.exports=a.p+"static/media/file_searching.cef1e739.svg"},634:function(e,t,a){e.exports=a.p+"static/media/file_system.c122b42a.svg"},635:function(e,t,a){e.exports=a.p+"static/media/files.74273f56.svg"},636:function(e,t,a){e.exports=a.p+"static/media/kg.38378845.svg"},637:function(e,t,a){e.exports=a.p+"static/media/medical_research.new.e507ee0f.svg"},638:function(e,t,a){e.exports=a.p+"static/media/medical_research.c8aab4c4.svg"},639:function(e,t,a){e.exports=a.p+"static/media/professor.new.84d78ec7.svg"},640:function(e,t,a){e.exports=a.p+"static/media/professor.c34907f3.svg"},641:function(e,t,a){e.exports=a.p+"static/media/report.new.f2bb8c12.svg"},642:function(e,t,a){e.exports=a.p+"static/media/report.f9ffaeee.svg"},643:function(e,t,a){e.exports=a.p+"static/media/reviewed_docs.new.951838fc.svg"},644:function(e,t,a){e.exports=a.p+"static/media/reviewed_docs.9899b647.svg"},645:function(e,t,a){e.exports=a.p+"static/media/undraw_annotation_7das.2bf1faf6.svg"},646:function(e,t,a){e.exports=a.p+"static/media/undraw_collecting_fjjl.a457acbb.svg"},647:function(e,t,a){e.exports=a.p+"static/media/undraw_detailed_analysis_xn7y.36330695.svg"},648:function(e,t,a){e.exports=a.p+"static/media/undraw_medical_research_qg4d.fba35ee6.svg"},649:function(e,t,a){e.exports=a.p+"static/media/undraw_professor_8lrt.c34907f3.svg"},650:function(e,t,a){e.exports=a.p+"static/media/undraw_report_mx0a.f9ffaeee.svg"},651:function(e,t,a){e.exports=a.p+"static/media/undraw_reviewed_docs_neeb.9899b647.svg"},652:function(e,t,a){e.exports=a.p+"static/media/logo.white.94d3e461.svg"},653:function(e,t,a){e.exports=a.p+"static/media/FacInformatica.c48fb5ab.jpg"},654:function(e,t,a){e.exports=a.p+"static/media/Logo_OEG.bc48c89c.jpg"},655:function(e,t,a){e.exports=a.p+"static/media/image.5799dfff.png"},656:function(e,t,a){e.exports=a.p+"static/media/oeg.33852d44.jpg"},657:function(e,t,a){e.exports=a.p+"static/media/upm.4d109cc0.png"},658:function(e,t){e.exports="data:image/png;base64,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"},659:function(e,t,a){e.exports=a.p+"static/media/AlbaFernandez.e7eaf598.png"},660:function(e,t,a){e.exports=a.p+"static/media/AnaIglesiasMolina.2926a2ea.jpg"},661:function(e,t,a){e.exports=a.p+"static/media/BeatrizL\xf3pezCenteno.e57035b2.jpg"},662:function(e,t,a){e.exports=a.p+"static/media/CarlosBadenesOlmedo.ae9fdc03.png"},663:function(e,t){e.exports="data:image/jpeg;base64,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"},664:function(e,t){e.exports="data:image/jpeg;base64,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"},665:function(e,t,a){e.exports=a.p+"static/media/EdnaRuckhaus.70f588f2.png"},666:function(e,t,a){e.exports=a.p+"static/media/ElviraAmador.9dc2ccf1.JPG"},667:function(e,t,a){e.exports=a.p+"static/media/EstebanGonz\xe1lezGuardia.92ac2690.jpeg"},668:function(e,t,a){e.exports=a.p+"static/media/Ignacio-IkerPrado-Rujas.147a354f.jpg"},669:function(e,t,a){e.exports=a.p+"static/media/JU_N.9c44f944.jpg"},670:function(e,t){e.exports="data:image/jpeg;base64,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"},671:function(e,t,a){e.exports=a.p+"static/media/MaydadePabloLlorente.51d8e4c8.png"},672:function(e,t,a){e.exports=a.p+"static/media/OscarCorcho.173cb033.jpeg"},673:function(e,t,a){e.exports=a.p+"static/media/PabloCallejaIba\xf1ez.0ee93c97.jpg"},674:function(e,t){e.exports="data:image/jpeg;base64,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"},675:function(e,t,a){e.exports=a.p+"static/media/PatriciaMart\xednChozas.ec10b577.png"},676:function(e,t,a){e.exports=a.p+"static/media/SocorroBernardos.847bee12.png"},677:function(e,t,a){e.exports=a.p+"static/media/VirginiadePablo.5ba516bb.png"},678:function(e,t){e.exports="data:image/jpeg;base64,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"},679:function(e,t,a){e.exports=a.p+"static/media/luisPozo.87e62936.png"},680:function(e,t,a){e.exports=a.p+"static/media/yoHead.2caa6138.png"},698:function(e,t,a){},705:function(e,t,a){"use strict";a.r(t);var n=a(1),i=a.n(n),o=a(8),r=a.n(o),s=(a(313),a(300)),l=a(64),c=(a(314),a(272),a(31)),A=a(32),d=a(130),u=a(33),m=a(34),p=(a(315),a(25)),g=a(97),y=a.n(g),h=(a(207),a(720)),b=a(709),f=a(710),x=a(717),v=a(104),E=a(719),k=a(273),j=a(725),w=("EN"!==document.location.href.toString().slice(-2)?p.default.navText[1]:p.default.navText[0],function(e){Object(m.a)(a,e);var t=Object(u.a)(a);function a(e){var n;return Object(c.a)(this,a),(n=t.call(this,e)).state={text:"EN"!==document.location.href.toString().slice(-2)?p.default.navText[1]:p.default.navText[0],collapsed:!0,activeKey:"introduction"},n.handleSetActive=n.handleSetActive.bind(Object(d.a)(n)),n}return Object(A.a)(a,[{key:"changeLang",value:function(){document.location.href="/lang/".concat(this.state.text.lang)}},{key:"handleSetActive",value:function(e){console.log("ESSTAMOS EN:"),console.log(e),this.setState({activeKey:e})}},{key:"render",value:function(){var e=this,t=Object.keys(this.state.text),a=t.indexOf("lang");return a>-1&&t.splice(a,1),i.a.createElement(h.a,null,i.a.createElement(b.a,{gutter:[16,16],style:{background:"#fff"}},i.a.createElement(f.a,{md:10},i.a.createElement("img",{src:y.a,className:"img-fluid d-inline-block align-top",alt:"",style:{height:50}})),i.a.createElement(f.a,{xs:2,md:14},i.a.createElement(x.a,{selectedKeys:[this.state.activeKey],mode:"horizontal",style:{borderBottom:"none"},overflowedIndicator:i.a.createElement(j.a,null)},t.map((function(t){return i.a.createElement(x.a.Item,{key:t},i.a.createElement(k.Link,{activeClass:"active",spy:!0,hashSpy:!0,smooth:!0,duration:500,to:t,onSetActive:e.handleSetActive},e.state.text[t]))})),i.a.createElement(x.a.Item,{className:"Item",key:"lang"},i.a.createElement(v.a,{title:"Translate to "+this.state.text.lang},i.a.createElement(E.a,{type:"secondary",onClick:function(){return e.changeLang()}},this.state.text.lang)))))))}}]),a}(i.a.Component)),D=a(723);function I(){return i.a.createElement("div",{className:"mt-xs-3 mt-md-5"},i.a.createElement(b.a,{justify:"",align:"middle"},i.a.createElement(f.a,{xs:12},i.a.createElement("div",{className:"m-2"},i.a.createElement("img",{src:y.a,alt:"DRUGS4COVID",style:{height:50},className:"img-fluid"}))),i.a.createElement(f.a,{xs:12},i.a.createElement(b.a,{style:{float:"right"}},i.a.createElement(f.a,null,i.a.createElement(v.a,{title:"@oeg_upm"},i.a.createElement("a",{href:"https://twitter.com/oeg_upm?s=20"},i.a.createElement("h3",{className:"blue"},i.a.createElement(D.a,null)))))))))}function B(e){return i.a.createElement(b.a,{type:"flex",justify:"center"},i.a.createElement(f.a,{xs:22,md:20,xl:18},i.a.createElement(w,null),e.children,i.a.createElement(I,null)))}var N=a(715),M=a(711),C=N.a.Title,S=N.a.Text;N.a.Paragraph;function O(e){return i.a.createElement("section",{className:"mt-xs-3 mt-md-5"},i.a.createElement(b.a,{gutter:[16,16]},i.a.createElement(f.a,{xs:24,md:14},i.a.createElement(C,{level:2},e.text.title1),i.a.createElement(S,null,e.text.text1)),i.a.createElement(f.a,{xs:24,md:10},i.a.createElement("div",{class:"embed-responsive embed-responsive-16by9"},i.a.createElement("iframe",{class:"embed-responsive-item",src:e.text.videoLink,allowfullscreen:!0})))),i.a.createElement(M.a,null))}var F=a(26);function H(e){var t={title:{visible:!0,text:e.text.title},description:{visible:!0,text:e.text.subtitle},forceFit:!0,data:e.data.values,padding:"auto",xField:e.data.xField,yField:e.data.yField,xAxis:e.data.xAxis,label:{visible:!0,style:{fill:"#0D0E68",fontSize:12,fontWeight:600,opacity:.6}}};return i.a.createElement(F.c,t)}var P=N.a.Title,R=(N.a.Text,N.a.Paragraph);function G(e){return i.a.createElement("div",{className:"mt-xs-3 mt-md-5"},i.a.createElement(P,{level:2},e.text.title0),i.a.createElement(b.a,{gutter:[16,16],type:"flex",align:"middle",justify:"center"},i.a.createElement(f.a,{xs:24,md:12},i.a.createElement(P,{level:4},e.text.title1),i.a.createElement(R,null,e.text.text1)),i.a.createElement(f.a,{xs:24,md:12},i.a.createElement(H,{data:e.data,text:e.text.graph1}))),i.a.createElement(M.a,null))}var Q=a(714);function U(e){var t={height:400,title:{visible:!0,text:e.text.title},description:{visible:!0,text:e.text.subtitle},padding:"auto",forceFit:!0,xField:e.data.xField,yField:e.data.yField,xAxis:e.data.xAxis,data:e.data.values};return i.a.createElement(F.a,t)}var q=N.a.Title,J=(N.a.Text,N.a.Paragraph);function W(e){return i.a.createElement("div",{className:"mt-xs-3 mt-md-5"},i.a.createElement(q,{level:2},e.text.title0),i.a.createElement(b.a,{gutter:[16,16]},i.a.createElement(f.a,{xs:24,md:12},i.a.createElement(q,{level:4},e.text.title1),i.a.createElement(J,null,e.text.text1))),i.a.createElement(b.a,{gutter:[16,16],align:"bottom",justify:"center"},i.a.createElement(f.a,{xs:24,md:12},i.a.createElement(U,{data:e.data.Line,text:e.text.graph1}),i.a.createElement(b.a,{justify:"center"},i.a.createElement(f.a,null,i.a.createElement(q,{level:4,type:"secondary"},e.text.graphtext1)))),i.a.createElement(f.a,{xs:24,md:12},i.a.createElement(Q.a,{size:"small",header:i.a.createElement(q,{level:4},e.data.List.title),bordered:!0,dataSource:e.data.List.items,renderItem:function(e){return i.a.createElement(Q.a.Item,null,i.a.createElement(Q.a.Item.Meta,{title:e.title,description:e.description}))}}),i.a.createElement(b.a,{justify:"center"},i.a.createElement(f.a,null,i.a.createElement(q,{level:4,type:"secondary"},e.text.graphtext2))))),i.a.createElement(M.a,null))}a(534);var V=a(716),T=a(718),z=(i.a.Component,N.a.Text),L=N.a.Title,K=N.a.Paragraph,Z=(V.a.Tabpane,function(e){var t=e.data;return i.a.createElement("div",null,t.lists.map((function(e,t){var a=!Array.isArray(e)&&Object.keys(e).includes("title")?e.title:"",n=Array.isArray(e)?e:e.data;return i.a.createElement("div",{className:0!==t?"mt-3":""},i.a.createElement(Q.a,{bordered:!0,header:""!==a?i.a.createElement(z,{strong:!0},a):null,dataSource:n,renderItem:function(e){return i.a.createElement(Q.a.Item,null,"link"===e.type?i.a.createElement("a",{href:e.link,target:"_blank"},e.text):"value"===e.type?e.text:"image"===e.type?i.a.createElement(b.a,{justify:"center"},i.a.createElement(f.a,{className:"text-center"},i.a.createElement(b.a,{justify:"center"},i.a.createElement(f.a,{className:"text-center"},i.a.createElement(z,{strong:!0,style:{whiteSpace:"pre-line"}},e.text))),i.a.createElement(b.a,{justify:"center"},i.a.createElement(f.a,{className:"text-center"},i.a.createElement("img",{src:e.link,className:"img-fluid",style:{maxWidth:"100%!important"},alt:""}))))):"json"===e.type?i.a.createElement(i.a.Fragment,null,i.a.createElement(b.a,null,i.a.createElement(f.a,{span:24},i.a.createElement(z,{strong:!0},e.text)),i.a.createElement(f.a,{span:24},i.a.createElement(z,{code:!0},e.code)))):"title"===e.type?i.a.createElement(z,{strong:!0},e.text):"")}}))})))}),Y=function(e){Object(m.a)(a,e);var t=Object(u.a)(a);function a(e){var n;return Object(c.a)(this,a),(n=t.call(this,e)).state={motivation:e.motivation,problems:e.problems,methodology:e.methodology,results:e.results,hypothesis:e.hypothesis,conclusions:e.conclusions},n}return Object(A.a)(a,[{key:"render",value:function(){var e=this;return i.a.createElement("div",{className:"py-3"},i.a.createElement("div",null,i.a.createElement(L,{level:3},this.state.motivation.title),i.a.createElement(K,{className:"text-justify"},this.state.motivation.text)),i.a.createElement("div",null,i.a.createElement(L,{level:3},this.state.problems.title),Object.keys(this.state.problems).includes("lists")?i.a.createElement(Z,{data:this.state.problems}):i.a.createElement(K,{className:"text-justify"},this.state.problems.text)),i.a.createElement("div",{className:"mt-3"},i.a.createElement(L,{level:3},this.state.hypothesis.title),i.a.createElement(K,{className:"text-justify"},this.state.hypothesis.text)),i.a.createElement("div",{className:"mt-3"},i.a.createElement(L,{level:3},this.state.methodology.title),i.a.createElement(Z,{data:this.state.methodology})),0!==Object.keys(this.state.results).length?i.a.createElement("div",{className:"mt-3"},i.a.createElement(L,{level:3},this.state.results.title),i.a.createElement(Z,{data:this.state.results})):"",0!==Object.keys(this.state.conclusions).length?i.a.createElement("div",{className:"mt-3"},i.a.createElement(L,{level:3},this.state.conclusions.title),Object.keys(this.state.conclusions).includes("text")?i.a.createElement(K,{className:"text-justify"},this.state.conclusions.text):Object.keys(this.state.conclusions).includes("lists")?i.a.createElement(Z,{data:this.state.conclusions}):i.a.createElement(b.a,{justify:"center",align:"middle",gutter:[16,16]},Object.keys(this.state.conclusions.statistics).map((function(t){return i.a.createElement(f.a,{className:"text-center"},i.a.createElement(T.a,{title:t,precision:2,value:e.state.conclusions.statistics[t]}))})))):"")}}]),a}(i.a.Component),X=a(127);function _(e){var t=e.data,a=e.buttonText;return console.log(t.info),i.a.createElement("div",{class:"card fullCard"},i.a.createElement("img",{src:X("./"+t.source),class:"card-img-top img-fluid p-2"}),i.a.createElement("div",{class:"card-body text-left d-flex flex-column"},i.a.createElement("div",{className:"mt-auto"},i.a.createElement("h5",{class:"card-title title pt-2 "},t.step,") ",t.title),i.a.createElement("p",{class:"card-text text-justify montserrat "},t.content))),i.a.createElement("div",{className:"card-footer whiteBg"},i.a.createElement(E.a,{type:"primary",className:"float-right","data-toggle":"modal","data-target":"#modal-"+t.step},a)),i.a.createElement("div",{class:"modal fade",id:"modal-"+t.step,tabindex:"-1",role:"dialog","aria-labelledby":"modal-label-"+t.step,"aria-hidden":"true"},i.a.createElement("div",{class:"modal-dialog modal-xl modal-dialog-scrollable",role:"document"},i.a.createElement("div",{class:"modal-content"},i.a.createElement("div",{class:"modal-header"},i.a.createElement("h2",{class:"modal-title",id:"modal-label-"+t.step},t.title),i.a.createElement("button",{type:"button",class:"close","data-dismiss":"modal","aria-label":"Close"},i.a.createElement("span",{"aria-hidden":"true"},"\xd7"))),i.a.createElement("div",{class:"modal-body  text-left"},i.a.createElement(Y,{motivation:t.info.motivation,hypothesis:t.info.hypothesis,problems:t.info.problems,methodology:t.info.methodology,results:t.info.results,conclusions:t.info.conclusions}))))))}var $=N.a.Title;N.a.Text,N.a.Paragraph;function ee(e){return i.a.createElement(i.a.Fragment,null,i.a.createElement(b.a,null,i.a.createElement(f.a,null,i.a.createElement($,{level:2},e.text.title0))),i.a.createElement("div",{className:"card-deck mt-5"},e.data.map((function(t){return i.a.createElement(_,{data:t,buttonText:e.text.text1})}))),i.a.createElement(M.a,null))}var te=a(724),ae=a(722),ne=a(726),ie=a(713),oe=a(721),re=a(127),se=N.a.Text;function le(e){var t=e.data,a=(e.gId,{DEV:{tooltip:"Developers Group",color:"magenta"},NLP:{tooltip:"Natural Language Processing Group",color:"purple"},KG:{tooltip:"Knowledge Graph Creation Group",color:"volcano"},Support:{tooltip:"Support and Advisory Group",color:"green"},CS:{tooltip:"Citizen Science Group",color:"cyan"}}),n=0===t.linkedin.length&&0===t.github.length&&0===t.twitter.length&&0===t.email.length;return i.a.createElement(i.a.Fragment,null,i.a.createElement(b.a,{justify:"center"},i.a.createElement(f.a,null,i.a.createElement(ie.a,{size:150,src:re("./"+t.source)}))),i.a.createElement(b.a,{justify:"center"},i.a.createElement(f.a,{className:"text-center"},i.a.createElement(se,{strong:!0},t.name))),i.a.createElement(b.a,{justify:"center",className:"mt-1"},i.a.createElement(f.a,{className:""},i.a.createElement(v.a,{title:a[t.group].tooltip},i.a.createElement(oe.a,{color:a[t.group].color},t.group))),0!==t.institution.length?i.a.createElement(f.a,{className:""},i.a.createElement(oe.a,{color:{UPM:"#1f82c0",SERMAS:"#d10002"}[t.institution]},t.institution)):""),i.a.createElement(b.a,{justify:"center",gutter:[8,8]},0!==t.twitter.length?i.a.createElement(f.a,null,i.a.createElement("a",{target:"_blank",href:"https://twitter.com/"+t.twitter},i.a.createElement(D.a,null))):"",0!==t.linkedin.length?i.a.createElement(f.a,null,i.a.createElement("a",{target:"_blank",href:t.linkedin},i.a.createElement(te.a,null))):"",0!==t.github.length?i.a.createElement(f.a,null,i.a.createElement("a",{target:"_blank",href:"https://github.com/"+t.github},i.a.createElement(ae.a,null))):"",0!==t.email.length?i.a.createElement(f.a,null,i.a.createElement("a",{target:"_blank",href:"mailto:"+t.email},i.a.createElement(ne.a,null))):"",n?i.a.createElement(f.a,null,i.a.createElement(ne.a,{style:{opacity:0}})):""))}function ce(e){var t=e.team;return console.log("ESTE EL TEAM"),console.log(t),i.a.createElement(b.a,{gutter:[16,16]},t.map((function(e){return i.a.createElement(f.a,{xs:12,md:8,lg:6,className:"col-xs-6 col-md-4 col-lg-3 py-2 align-self-center"},i.a.createElement(le,{data:e}))})))}var Ae=a(127),de=N.a.Title;N.a.Text,N.a.Paragraph;function ue(e){return i.a.createElement(i.a.Fragment,null,i.a.createElement(b.a,null,i.a.createElement(f.a,null,i.a.createElement(de,{level:2},e.text.title0))),i.a.createElement(b.a,null,i.a.createElement(f.a,null,i.a.createElement(de,{level:4},e.text.title1))),i.a.createElement(b.a,{justify:"center"},i.a.createElement(f.a,null,i.a.createElement(ce,{team:e.data}))),i.a.createElement(b.a,null,i.a.createElement(f.a,null,i.a.createElement(de,{level:4},e.text.title2))),i.a.createElement(b.a,{justify:"center",align:"bottom"},i.a.createElement(f.a,{xs:24,md:8,className:"text-center"},i.a.createElement("img",{src:Ae("./"+e.text.logo1),alt:"",className:"img-fluid"})),i.a.createElement(f.a,{xs:24,md:8,className:"text-center"},i.a.createElement("img",{src:Ae("./"+e.text.logo2),alt:"",className:"img-fluid"})),i.a.createElement(f.a,{xs:24,md:8,className:"text-center"},i.a.createElement("img",{src:Ae("./"+e.text.logo3),alt:"",className:"img-fluid"}))),i.a.createElement(M.a,null))}a(127);function me(e){var t=null;try{t=e.match.params.lang}catch(n){console.log(n)}var a="EN"===t?p.default.languages[1]:p.default.languages[0];return i.a.createElement(B,null,i.a.createElement("div",{className:"",id:"introduction"},i.a.createElement(O,{text:a.info})),i.a.createElement("div",{className:"pt-5",id:"problem"},i.a.createElement(G,{text:a.problems,data:p.default.MedicineStock})),i.a.createElement("div",{className:"pt-5",id:"resources"},i.a.createElement(W,{text:a.resources,data:{Line:p.default.ArticlesPerYear,List:p.default.List}})),i.a.createElement("div",{className:"pt-5",id:"approach"},i.a.createElement(ee,{text:a.approach,data:a.approach.data})),i.a.createElement("div",{id:"team",className:"pt-5"},i.a.createElement(ue,{text:a.team,data:p.default.teamData})))}i.a.Component;function pe(e){return i.a.createElement(i.a.Fragment,null,function(){switch(e.data.type){case"bar":return i.a.createElement(F.b,e.data.config);case"line":return i.a.createElement(F.f,e.data.config);case"area":return i.a.createElement(F.a,e.data.config);case"wordcloud":return i.a.createElement(F.i,e.data.config);case"column":return i.a.createElement(F.c,e.data.config);case"groupedcolumn":return i.a.createElement(F.e,e.data.config);case"gauge":return i.a.createElement(F.d,e.data.config);case"overlappedcombo":return i.a.createElement(F.g,e.data.config);case"stepline":return i.a.createElement(F.h,e.data.config);default:return i.a.createElement("h1",null,"ALGO VA MAL")}}())}a(681);var ge=function(e){Object(m.a)(a,e);var t=Object(u.a)(a);function a(e){var n;return Object(c.a)(this,a),(n=t.call(this,e)).state={data:[],size:12},n}return Object(A.a)(a,[{key:"render",value:function(){var e=this;return i.a.createElement(i.a.Fragment,null,i.a.createElement(b.a,{justify:"center",align:"middle",gutter:[16,16]},this.state.data.map((function(t){return i.a.createElement(f.a,{className:"text-center p-1",xs:24,md:e.state.size},i.a.createElement(pe,{data:t}))}))))}},{key:"componentDidMount",value:function(){var e=this;new Promise((function(e,t){e([{type:"line",config:{title:{visible:!0,text:"2000 ~ 2018 "},description:{visible:!0,text:"This is the description"},forceFit:!0,data:[{name:"China",year:"2000",gdp:1211346869605.24},{name:"China",year:"2001",gdp:1339395718865.3},{name:"China",year:"2002",gdp:1470550015081.55},{name:"China",year:"2003",gdp:1660287965662.68},{name:"China",year:"2004",gdp:1955347004963.27},{name:"China",year:"2005",gdp:2285965892360.54},{name:"China",year:"2006",gdp:2752131773355.16},{name:"China",year:"2007",gdp:3550342425238.25},{name:"China",year:"2008",gdp:4594306848763.08},{name:"China",year:"2009",gdp:5101702432883.45},{name:"China",year:"2010",gdp:6087164527421.24},{name:"China",year:"2011",gdp:7551500425597.77},{name:"China",year:"2012",gdp:8532230724141.76},{name:"China",year:"2013",gdp:9570405758739.79},{name:"China",year:"2014",gdp:10438529153237.6},{name:"China",year:"2015",gdp:11015542352468.9},{name:"China",year:"2016",gdp:11137945669350.6},{name:"China",year:"2017",gdp:12143491448186.1},{name:"China",year:"2018",gdp:13608151864637.9},{name:"United States",year:"2000",gdp:0x9530f68d4c0},{name:"United States",year:"2001",gdp:0x99fc5b49fd8},{name:"United States",year:"2002",gdp:0x9f2555f71b0},{name:"United States",year:"2003",gdp:0xa6bd48e5c70},{name:"United States",year:"2004",gdp:0xb1bbafcb878},{name:"United States",year:"2005",gdp:0xbdb544f5688},{name:"United States",year:"2006",gdp:0xc9077018bf0},{name:"United States",year:"2007",gdp:1445185865e4},{name:"United States",year:"2008",gdp:0xd6199d86320},{name:"United States",year:"2009",gdp:0xd24278534e8},{name:"United States",year:"2010",gdp:0xda29bfa2cd8},{name:"United States",year:"2011",gdp:0xe22ca068d80},{name:"United States",year:"2012",gdp:0xebb28de9508},{name:"United States",year:"2013",gdp:1678484919e4},{name:"United States",year:"2014",gdp:0xfef997a5e70},{name:"United States",year:"2015",gdp:18219297584e3},{name:"United States",year:"2016",gdp:18707188235e3},{name:"United States",year:"2017",gdp:19485393853e3},{name:"United States",year:"2018",gdp:20544343456936.5},{name:"United Kingdom",year:"2000",gdp:1657816613708.58},{name:"United Kingdom",year:"2001",gdp:1640246149417.01},{name:"United Kingdom",year:"2002",gdp:1784473920863.31},{name:"United Kingdom",year:"2003",gdp:2053018775510.2},{name:"United Kingdom",year:"2004",gdp:2416931526913.22},{name:"United Kingdom",year:"2005",gdp:253868e7},{name:"United Kingdom",year:"2006",gdp:2713749770009.2},{name:"United Kingdom",year:"2007",gdp:3100882352941.18},{name:"United Kingdom",year:"2008",gdp:2922667279411.76},{name:"United Kingdom",year:"2009",gdp:2410909799034.12},{name:"United Kingdom",year:"2010",gdp:2475244321361.11},{name:"United Kingdom",year:"2011",gdp:2659310054646.23},{name:"United Kingdom",year:"2012",gdp:2704887678386.72},{name:"United Kingdom",year:"2013",gdp:2786022872706.81},{name:"United Kingdom",year:"2014",gdp:3063803240208.01},{name:"United Kingdom",year:"2015",gdp:2928591002002.51},{name:"United Kingdom",year:"2016",gdp:2694283209613.29},{name:"United Kingdom",year:"2017",gdp:2666229179958.01},{name:"United Kingdom",year:"2018",gdp:2855296731521.96},{name:"Russian",year:"2000",gdp:259710142196.94},{name:"Russian",year:"2001",gdp:306602070620.5},{name:"Russian",year:"2002",gdp:345470494417.86},{name:"Russian",year:"2003",gdp:430347770731.79},{name:"Russian",year:"2004",gdp:591016690742.8},{name:"Russian",year:"2005",gdp:764017107992.39},{name:"Russian",year:"2006",gdp:989930542278.7},{name:"Russian",year:"2007",gdp:1299705764823.62},{name:"Russian",year:"2008",gdp:1660846387624.78},{name:"Russian",year:"2009",gdp:1222644282201.86},{name:"Russian",year:"2010",gdp:1524917468442.01},{name:"Russian",year:"2011",gdp:2051661732059.78},{name:"Russian",year:"2012",gdp:2210256976945.38},{name:"Russian",year:"2013",gdp:2297128039058.21},{name:"Russian",year:"2014",gdp:2059984158438.46},{name:"Russian",year:"2015",gdp:1363594369577.82},{name:"Russian",year:"2016",gdp:1282723881134.01},{name:"Russian",year:"2017",gdp:1578624060588.26},{name:"Russian",year:"2018",gdp:1657554647149.87},{name:"Japan",year:"2000",gdp:4887519660744.86},{name:"Japan",year:"2001",gdp:4303544259842.72},{name:"Japan",year:"2002",gdp:4115116279069.77},{name:"Japan",year:"2003",gdp:4445658071221.86},{name:"Japan",year:"2004",gdp:4815148854362.11},{name:"Japan",year:"2005",gdp:4755410630912.14},{name:"Japan",year:"2006",gdp:4530377224970.4},{name:"Japan",year:"2007",gdp:4515264514430.57},{name:"Japan",year:"2008",gdp:5037908465114.48},{name:"Japan",year:"2009",gdp:5231382674593.7},{name:"Japan",year:"2010",gdp:5700098114744.41},{name:"Japan",year:"2011",gdp:6157459594823.72},{name:"Japan",year:"2012",gdp:6203213121334.12},{name:"Japan",year:"2013",gdp:5155717056270.83},{name:"Japan",year:"2014",gdp:4850413536037.84},{name:"Japan",year:"2015",gdp:4389475622588.97},{name:"Japan",year:"2016",gdp:4926667087367.51},{name:"Japan",year:"2017",gdp:4859950558538.97},{name:"Japan",year:"2018",gdp:4971323079771.87}],xField:"year",yField:"gdp",seriesField:"name",xAxis:{type:"dateTime",label:{visible:!0,autoHide:!0}},yAxis:{formatter:function(e){return"".concat((e/1e9).toFixed(1)," B")}},legend:{visible:!1},label:{visible:!0,type:"line"},animation:{appear:{animation:"clipingWithData"}},smooth:!0}},{type:"groupedcolumn",config:{title:{visible:!0,text:"\u5206\u7ec4\u67f1\u72b6\u56fe"},forceFit:!0,data:[{name:"London",month:"Jan.",value:18.9},{name:"London",month:"Feb.",value:28.8},{name:"London",month:"Mar.",value:39.3},{name:"London",month:"Apr.",value:81.4},{name:"London",month:"May",value:47},{name:"London",month:"Jun.",value:20.3},{name:"London",month:"Jul.",value:24},{name:"London",month:"Aug.",value:35.6},{name:"Berlin",month:"Jan.",value:12.4},{name:"Berlin",month:"Feb.",value:23.2},{name:"Berlin",month:"Mar.",value:34.5},{name:"Berlin",month:"Apr.",value:99.7},{name:"Berlin",month:"May",value:52.6},{name:"Berlin",month:"Jun.",value:35.5},{name:"Berlin",month:"Jul.",value:37.4},{name:"Berlin",month:"Aug.",value:42.4}],xField:"month",yField:"value",yAxis:{min:0},label:{visible:!0},groupField:"name",color:["#1ca9e6","#f88c24"]}},{type:"stepline",config:{title:{visible:!0,text:"Random Title"},description:{visible:!0,text:"Random Subtitle"},forceFit:!0,padding:"auto",data:[{year:"1991",value:3},{year:"1992",value:4},{year:"1993",value:3.5},{year:"1994",value:5},{year:"1995",value:4.9},{year:"1996",value:6},{year:"1997",value:7},{year:"1998",value:9},{year:"1999",value:13}],xField:"year",yField:"value",point:{visible:!0},label:{visible:!0,type:"point"}}},{type:"overlappedcombo",config:{layers:[{type:"groupedColumn",name:"\u8ba2\u5355\u91cf",data:[{time:"2019-03",value:350,type:"uv"},{time:"2019-04",value:900,type:"uv"},{time:"2019-05",value:300,type:"uv"},{time:"2019-06",value:450,type:"uv"},{time:"2019-07",value:470,type:"uv"},{time:"2019-03",value:220,type:"bill"},{time:"2019-04",value:300,type:"bill"},{time:"2019-05",value:250,type:"bill"},{time:"2019-06",value:220,type:"bill"},{time:"2019-07",value:362,type:"bill"}],xField:"time",yField:"value",groupField:"type"},{type:"line",name:"\u8f6c\u5316",data:[{time:"2019-03",value:800},{time:"2019-04",value:600},{time:"2019-05",value:400},{time:"2019-06",value:380},{time:"2019-07",value:220}],xField:"time",yField:"value",color:"#f8ca45",lineSize:2}]}}])})).then((function(t){e.setState({data:t})}))}}]),a}(i.a.Component),ye="Ribavirin is gonadotoxic and teratogenic in multiple species.",he=function(e){Object(m.a)(a,e);var t=Object(u.a)(a);function a(e){var n;return Object(c.a)(this,a),(n=t.call(this,e)).state={words:ye.split(" "),selected:Array(ye.split(" ").length).fill(!1)},n}return Object(A.a)(a,[{key:"selectedWord",value:function(e){var t=this.state.selected;t[e]=!this.state.selected[e],this.setState({selected:t})}},{key:"render",value:function(){return i.a.createElement(B,null,i.a.createElement(ge,null))}}]),a}(i.a.Component);a(698),a(699),a(700),a(271),a(701),a(703);var be=function(){return i.a.createElement(s.a,null,i.a.createElement(l.c,null,i.a.createElement(l.a,{path:"/lang/:lang",component:me}),i.a.createElement(l.a,{exact:!0,path:"/",component:me}),i.a.createElement(l.a,{exact:!0,path:"/cs",component:he})))};Boolean("localhost"===window.location.hostname||"[::1]"===window.location.hostname||window.location.hostname.match(/^127(?:\.(?:25[0-5]|2[0-4][0-9]|[01]?[0-9][0-9]?)){3}$/));r.a.render(i.a.createElement(i.a.StrictMode,null,i.a.createElement(be,null)),document.getElementById("root")),"serviceWorker"in navigator&&navigator.serviceWorker.ready.then((function(e){e.unregister()})).catch((function(e){console.error(e.message)}))},97:function(e,t,a){e.exports=a.p+"static/media/logo.aa6b7ebb.svg"}},[[308,1,2]]]);
//# sourceMappingURL=main.4dadf67d.chunk.js.map